Late Tenecteplase Not Beneficial for Stroke Patients With LVOs
PHOENIX — Selected stroke patients did not benefit clinically from having the window of tenecteplase therapy extended beyond the first few hours of stroke onset, the randomized TIMELESS trial found. In patients with large-vessel occlusions (LVOs) and evidence of salvageable tissue on perfusion imaging — most who also received endovascular thrombectomy — functional outcomes at […]
Lorundrostat Stands a Chance Against Obesity-Related Hypertension
Among selected people with uncontrolled hypertension, blood pressure (BP) could be successfully reduced with a highly selective aldosterone synthase inhibitor, a phase II dose-finding trial found. In hypertensive patients with suppressed renin — theoretically the group most likely to benefit from reining in aldosterone production — reductions of automated office systolic BP reached up to […]
Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancer
Metastasis-directed therapy (MDT) in selected patients with recurrent oligometastatic prostate cancer led to PSA responses in a majority of patients and delayed initiation of hormonal therapy by 18 months, a retrospective study showed. Overall, 77 of 124 patients had PSA declines of more than 50% with surgery or stereotactic body radiation therapy (SBRT). In particular, […]
Improved Survival With Surgery in Metastatic Breast Cancer
Selected patients with metastatic breast cancer at diagnosis had significantly better survival with surgery in addition to systemic therapy, an analysis of almost 13,000 patients showed. Overall, the survival hazard improved by 27%-36% in women with known receptor status (estrogen, progesterone, and HER2) treated with systemic therapy plus surgery with or without radiation therapy. Women […]